About Us | Society for RNA Therapeutics

Our Mission

The Society for RNA Therapeutics (SRT) is a global network to support translational research and development of RNA therapeutics; to develop standards for RNA manufacturing, guidelines for clinical trials, and to facilitate public-private-regulatory partnerships and to advocate for accessible RNA therapeutics for all patients.

SRT aims to provide public and professional education and develop training guidelines; to advocate for patients with diseases amenable to RNA therapies; to develop clinical best practices in RNA therapeutics; to support early career and professional development; and to advocate accessibility to RNA therapeutics for low and middle income countries for the enhancement of global health.

Our Team

John P. Cooke, M.D., Ph.D.

President

Bruce A. Sullenger, Ph.D.

Vice President

Lior Zangi, Ph.D.

Treasurer

Andrew Varley, Ph.D.

Secretary

Jeremy E. Wilusz, Ph.D.

Chief of Staff

Luke Thorstenson, MBA

Executive Director

Board of Directors

Jeff Coller, Ph.D.

Board Member

Bloomberg Distinguished Professor of RNA Biology and Therapeutics
Johns Hopkins University
Baltimore, MD USA

John P. Cooke, M.D., Ph.D.

President, Board Member

Medical Director, Center for RNA Therapeutics
Chief Translational Officer, Houston Methodist Academic Institute
Houston, TX USA

Pieter R. Cullis, Ph.D., FRSC, FNAI

Board Member

Professor, Department of Biochemistry and Molecular Biology, UBC
Founding Director, Centre for Drug Research and Development
Vancouver, BC Canada

Michelle L. Hastings, Ph.D.

Board Member

Pfizer Upjohn Research Professor of Pharmacology
Director, M-RNA Therapeutics
University of Michigan Medical School
Ann Arbor, MI USA

Adrian Krainer, Ph.D.

Board Member

St. Giles Foundation Professor
Cancer Center Deputy Director of Research
Cold Spring Harbor Laboratory
Cold Spring Harbor, NY USA

Prof. Dan Peer, Ph.D.

Board Member

Director, Laboratory of Precision NanoMedicine
Shmunis School for Biomedicine and Cancer Research
Tel Aviv University
Ramat Aviv, Tel-Aviv, Israel

Anna Marie Pyle, Ph.D.

Board Member

Sterling Professor of Molecular, Cellular and Developmental Biology and Professor of Chemistry
Yale University
New Haven, CT USA

John J. Rossi, Ph.D.

Board Member

Professor and Director, Center for RNA Biology and Therapeutics
Dean Emeritus, Irell & Manella Graduate School of Biological Sciences
City of Hope
Duarte, CA USA

Bruce A. Sullenger, Ph.D.

Vice President, Board Member

Joseph and Dorothy Beard Professor, Department of Surgery
Duke University
Durham, NC USA

Andrew Varley, Ph.D.

Secretary, Board Member

Founding Director & Head of R&D, RNA & Formulation Core
The University of British Columbia
Vancouver, BC Canada

Drew Weissman, M.D., Ph.D.

Board Member

2023 Nobel Laureate in Medicine
Professor in Medicine, University of Pennsylvania
Roberts Family Professor in Vaccine Research
Director, Penn Institute for RNA Innovation
Philadelphia, PA USA

Jeremy E. Wilusz, Ph.D.

Chief of Staff, Board Member

Ruth McLean Bowmen Bowers Professor, Department of Biochemistry and Molecular Pharmacology
Director of Academic Development, Therapeutic Innovation Center
Baylor College of Medicine
Houston, TX USA

Timothy Yu, M.D., Ph.D.

Board Member

Attending Physician, Division of Genetics and Genomics
Associate Professor of Pediatrics, Harvard Medical School
Boston Children's Hospital
Boston, MA USA

Lior Zangi, Ph.D.

Treasurer, Board Member

Associate Professor, Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
New York, NY USA